Click for best price
Vaccines Market Size, Share 2023
| Market size in 2022 |
US$ 46590 million
|
Forecast Market size by 2029 |
US$ 67140 million
|
| Growth Rate |
CAGR of 5.4% |
Number of Pages |
77 Pages |
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
This report aims to provide a comprehensive presentation of the global market for Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines. This report contains market size and forecasts of Vaccines in global, including the following market information:
Global top five Vaccines companies in 2022 (%)
The global Vaccines market was valued at US$ 46590 million in 2022 and is projected to reach US$ 67140 million by 2029, at a CAGR of 5.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
We surveyed the Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vaccines Market Segment Percentages, by Type, 2022 (%)
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
Global Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vaccines Market Segment Percentages, by Application, 2022 (%)
- Rabies vaccine
- Influenza vaccine
- HPV vaccine
- Hepatitis B
- Hepatitis A
- Leprosy vaccine
- Polio vaccine
- JE vaccine
- Others
Global Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Vaccines revenues share in global market, 2022 (%)
- Key companies Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Vaccines sales share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- GSK
- Sanofi
- Merck
- Pfizer
- Novartis(GSK)
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
- Jintan
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Vaccines, market overview.
- Chapter 2: Global Vaccines market size in revenue and volume.
- Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Vaccines capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 46590 million
|
| Forecast Market size by 2029 |
US$ 67140 million
|
| Growth Rate |
CAGR of 5.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
77 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccines Overall Market Size
2.1 Global Vaccines Market Size: 2022 VS 2029
2.2 Global Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Vaccines Players in Global Market
3.2 Top Global Vaccines Companies Ranked by Revenue
3.3 Global Vaccines Revenue by Companies
3.4 Global Vaccines Sales by Companies
3.5 Global Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Vaccines Market Size Markets, 2022 & 2029
4.1.2 Recombinant Vaccines
4.1.3 Viral Vaccines
4.1.4 Polysaccharide Vaccines
4.1.5 Others
4.2 By Type - Global Vaccines Revenue & Forecasts
4.2.1 By Type - Global Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Vaccines Sales & Forecasts
4.3.1 By Type - Global Vaccines Sales, 2018-2023
4.3.2 By Type - Global Vaccines Sales, 2024-2029
4.3.3 By Type - Global Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vaccines Market Size, 2022 & 2029
5.1.2 Rabies vaccine
5.1.3 Influenza vaccine
5.1.4 HPV vaccine
5.1.5 Hepatitis B
5.1.6 Hepatitis A
5.1.7 Leprosy vaccine
5.1.8 Polio vaccine
5.1.9 JE vaccine
5.1.10 Others
5.2 By Application - Global Vaccines Revenue & Forecasts
5.2.1 By Application - Global Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Vaccines Sales & Forecasts
5.3.1 By Application - Global Vaccines Sales, 2018-2023
5.3.2 By Application - Global Vaccines Sales, 2024-2029
5.3.3 By Application - Global Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Vaccines Revenue & Forecasts
6.2.1 By Region - Global Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Vaccines Sales & Forecasts
6.3.1 By Region - Global Vaccines Sales, 2018-2023
6.3.2 By Region - Global Vaccines Sales, 2024-2029
6.3.3 By Region - Global Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Vaccines Sales, 2018-2029
6.4.3 US Vaccines Market Size, 2018-2029
6.4.4 Canada Vaccines Market Size, 2018-2029
6.4.5 Mexico Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Vaccines Sales, 2018-2029
6.5.3 Germany Vaccines Market Size, 2018-2029
6.5.4 France Vaccines Market Size, 2018-2029
6.5.5 U.K. Vaccines Market Size, 2018-2029
6.5.6 Italy Vaccines Market Size, 2018-2029
6.5.7 Russia Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Vaccines Market Size, 2018-2029
6.5.9 Benelux Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Vaccines Sales, 2018-2029
6.6.3 China Vaccines Market Size, 2018-2029
6.6.4 Japan Vaccines Market Size, 2018-2029
6.6.5 South Korea Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Vaccines Market Size, 2018-2029
6.6.7 India Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Vaccines Sales, 2018-2029
6.7.3 Brazil Vaccines Market Size, 2018-2029
6.7.4 Argentina Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Vaccines Sales, 2018-2029
6.8.3 Turkey Vaccines Market Size, 2018-2029
6.8.4 Israel Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Vaccines Market Size, 2018-2029
6.8.6 UAE Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Vaccines Major Product Offerings
7.1.4 GSK Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Vaccines Major Product Offerings
7.2.4 Sanofi Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Vaccines Major Product Offerings
7.3.4 Merck Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Vaccines Major Product Offerings
7.4.4 Pfizer Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Novartis(GSK)
7.5.1 Novartis(GSK) Company Summary
7.5.2 Novartis(GSK) Business Overview
7.5.3 Novartis(GSK) Vaccines Major Product Offerings
7.5.4 Novartis(GSK) Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Novartis(GSK) Key News & Latest Developments
7.6 CSL
7.6.1 CSL Company Summary
7.6.2 CSL Business Overview
7.6.3 CSL Vaccines Major Product Offerings
7.6.4 CSL Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 CSL Key News & Latest Developments
7.7 MedImmune LLC
7.7.1 MedImmune LLC Company Summary
7.7.2 MedImmune LLC Business Overview
7.7.3 MedImmune LLC Vaccines Major Product Offerings
7.7.4 MedImmune LLC Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 MedImmune LLC Key News & Latest Developments
7.8 J&J(Crucell)
7.8.1 J&J(Crucell) Company Summary
7.8.2 J&J(Crucell) Business Overview
7.8.3 J&J(Crucell) Vaccines Major Product Offerings
7.8.4 J&J(Crucell) Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 J&J(Crucell) Key News & Latest Developments
7.9 China National Biotec
7.9.1 China National Biotec Company Summary
7.9.2 China National Biotec Business Overview
7.9.3 China National Biotec Vaccines Major Product Offerings
7.9.4 China National Biotec Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 China National Biotec Key News & Latest Developments
7.10 Tiantan
7.10.1 Tiantan Company Summary
7.10.2 Tiantan Business Overview
7.10.3 Tiantan Vaccines Major Product Offerings
7.10.4 Tiantan Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Tiantan Key News & Latest Developments
7.11 Hualan
7.11.1 Hualan Company Summary
7.11.2 Hualan Vaccines Business Overview
7.11.3 Hualan Vaccines Major Product Offerings
7.11.4 Hualan Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 Hualan Key News & Latest Developments
7.12 Kangtai
7.12.1 Kangtai Company Summary
7.12.2 Kangtai Vaccines Business Overview
7.12.3 Kangtai Vaccines Major Product Offerings
7.12.4 Kangtai Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Kangtai Key News & Latest Developments
7.13 Hissen
7.13.1 Hissen Company Summary
7.13.2 Hissen Vaccines Business Overview
7.13.3 Hissen Vaccines Major Product Offerings
7.13.4 Hissen Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Hissen Key News & Latest Developments
7.14 Jintan
7.14.1 Jintan Company Summary
7.14.2 Jintan Business Overview
7.14.3 Jintan Vaccines Major Product Offerings
7.14.4 Jintan Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 Jintan Key News & Latest Developments
8 Global Vaccines Production Capacity, Analysis
8.1 Global Vaccines Production Capacity, 2018-2029
8.2 Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vaccines Supply Chain Analysis
10.1 Vaccines Industry Value Chain
10.2 Vaccines Upstream Market
10.3 Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Vaccines in Global Market
Table 2. Top Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Vaccines Product Type
Table 9. List of Global Tier 1 Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Vaccines Sales, (K Units), 2024-2029
Table 46. GSK Company Summary
Table 47. GSK Vaccines Product Offerings
Table 48. GSK Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Vaccines Product Offerings
Table 52. Sanofi Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Vaccines Product Offerings
Table 56. Merck Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Vaccines Product Offerings
Table 60. Pfizer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Novartis(GSK) Company Summary
Table 63. Novartis(GSK) Vaccines Product Offerings
Table 64. Novartis(GSK) Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Novartis(GSK) Key News & Latest Developments
Table 66. CSL Company Summary
Table 67. CSL Vaccines Product Offerings
Table 68. CSL Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. CSL Key News & Latest Developments
Table 70. MedImmune LLC Company Summary
Table 71. MedImmune LLC Vaccines Product Offerings
Table 72. MedImmune LLC Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. MedImmune LLC Key News & Latest Developments
Table 74. J&J(Crucell) Company Summary
Table 75. J&J(Crucell) Vaccines Product Offerings
Table 76. J&J(Crucell) Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. J&J(Crucell) Key News & Latest Developments
Table 78. China National Biotec Company Summary
Table 79. China National Biotec Vaccines Product Offerings
Table 80. China National Biotec Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. China National Biotec Key News & Latest Developments
Table 82. Tiantan Company Summary
Table 83. Tiantan Vaccines Product Offerings
Table 84. Tiantan Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Tiantan Key News & Latest Developments
Table 86. Hualan Company Summary
Table 87. Hualan Vaccines Product Offerings
Table 88. Hualan Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Hualan Key News & Latest Developments
Table 90. Kangtai Company Summary
Table 91. Kangtai Vaccines Product Offerings
Table 92. Kangtai Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Kangtai Key News & Latest Developments
Table 94. Hissen Company Summary
Table 95. Hissen Vaccines Product Offerings
Table 96. Hissen Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Hissen Key News & Latest Developments
Table 98. Jintan Company Summary
Table 99. Jintan Vaccines Product Offerings
Table 100. Jintan Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Jintan Key News & Latest Developments
Table 102. Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Vaccines Production by Region, 2018-2023 (K Units)
Table 105. Global Vaccines Production by Region, 2024-2029 (K Units)
Table 106. Vaccines Market Opportunities & Trends in Global Market
Table 107. Vaccines Market Drivers in Global Market
Table 108. Vaccines Market Restraints in Global Market
Table 109. Vaccines Raw Materials
Table 110. Vaccines Raw Materials Suppliers in Global Market
Table 111. Typical Vaccines Downstream
Table 112. Vaccines Downstream Clients in Global Market
Table 113. Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Vaccines Segment by Type in 2022
Figure 2. Vaccines Segment by Application in 2022
Figure 3. Global Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Vaccines Revenue in 2022
Figure 9. By Type - Global Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Vaccines Sales Market Share, 2018-2029
Figure 23. US Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Vaccines Sales Market Share, 2018-2029
Figure 37. China Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Vaccines by Region, 2022 VS 2029
Figure 54. Vaccines Industry Value Chain
Figure 55. Marketing Channels
